Rankings
▼
Calendar
DBVT
DBV Technologies S.A.
$538M
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+18.0% YoY
Gross Profit
$2M
100.0% margin
Operating Income
-$44M
-2307.3% margin
Net Income
-$45M
-2346.8% margin
EPS (Diluted)
$-9.05
QoQ Revenue Growth
+1.5%
Cash Flow
Operating Cash Flow
-$35M
Free Cash Flow
-$37M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$250M
Total Liabilities
$67M
Stockholders' Equity
$183M
Cash & Equivalents
$194M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
+18.0%
Gross Profit
$2M
$930,954
+106.3%
Operating Income
-$44M
-$35M
-26.3%
Net Income
-$45M
-$34M
-31.6%
← FY 2017
All Quarters
Q1 2018 →
DBVT Q4 2017 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena